OMODA & JAECOO Brings OMODA 4 and OMODA 7 to 2026 Beijing Auto Show in a Show of Global Strength 
Solutionz Group LLC Announces Launch of G2 Framework to Expand Revenue and Engagement from Existing Audiences 
Dawn Michelle Castrataro Joins Entrepreneur of Impact Competition 
OMODA Global Music Festival Kicks Off: “Auto Grommy” Trendsetting Sound Feast Redefining Global Youth Trends 
Beyond the Domain: The Domain Name Company Launches Global ‘Ventures’ Program to Help Build Startups from the Ground Up Biomea Fusion to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference
REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a…
Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 22, 2022, at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., March 15, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
ExCellThera announces new data to be presented at the EBMT 2022 annual meeting
MONTRÉAL, March 15, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and…
Trusting Heart Blood Center Holds Ribbon Cutting Ceremony for Opening of its Second Platelet Donation Site
Photo 1 Reception at New Trusting Heart Blood Center – Raleigh, North Carolina Photo 2…
Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
First Participants Dosed in Phase 2a Study of Pan-Antiviral Nasal Spray
ENA Respiratory begins influenza challenge study for fast-acting nasal spray INNA-051, designed to boost innate…
PepGen Announces Approval by Health Canada of CTA to Begin First in Human Trials of PGN-EDO51 to Treat Duchenne Muscular Dystrophy
Updates on preclinical data and the clinical development plan will be presented at the Muscular…
Neoleukin Therapeutics Announces Appointment of Donna Cochener as General Counsel
SEATTLE, March 15, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Eyenovia Announces Positive Study Results Demonstrating that its Optejet® Delivery Technology Reduces Conjunctival Cell Toxicity from Preserved Ophthalmic Solutions to a Level Comparable with Non-Preserved Solutions
Study conducted with Tufts Medical Center represents a breakthrough showing that Microdose Array Print (MAP™)…
Elicio Therapeutics Moves into Boston’s Seaport District and Provides Update on Programs
The Company has moved from Cambridge, MA to a new, larger space in the Seaport…
Werewolf Therapeutics Announces Upcoming Presentations at AACR 2022 Annual Meeting
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
Longeveron to Present at Oppenheimer 32nd Annual Healthcare Conference
MIAMI, March 15, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical…
Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer
– Dr. Dias is a biotech and pharma industry executive with more than 20 years…
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results
Ovid executing on its strategy to build a leading epilepsy pipeline OV329 expected to enter…
INmune Bio, Inc. Announces Nine Data Presentations at AD/PD™ 2022 – International Conference on Alzheimer’s and Parkinson’s Diseases
Conference Provides First Exposure of EU and UK AD Experts to INmune Bio’s Approach of…
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
SEATTLE and VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
PDS Biotech Announces Achievement of an Enrollment Objective in National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination in Advanced HPV-Associated Cancers
NCI achieves the enrollment objective of thirty patients in the checkpoint inhibitor refractory arm of…
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2021 on March 29th at 4:30 p.m. Eastern Time
ROCKVILLE, Md., March 15, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the…
Otonomy to Host Virtual Investor R&D Event on March 22, 2022
SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated…
Surface Oncology Appoints Theresa Boni as General Counsel
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…